Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01168427 · ClinicalTrials.gov registry record
Reveal In-Office Implants
A clinical trial, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- Completed
- Registry status
- 66
- Enrollment target
NCT01168427 is a clinical trial that has completed, run by Medtronic Cardiac Rhythm and Heart Failure. The registered enrollment target is 66 participants.
The verdict
NCT01168427 has completed, sponsored by Medtronic Cardiac Rhythm and Heart Failure.
- COMPLETED
- Registry status
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to gather evidence about the safety and feasibility of performing the implant procedure for the Reveal Insertable Cardiac Monitor (ICM) in an office or clinic setting rather than the traditional hospital operating room, cardiac catheterization or electrophysiology (EP) laboratory setting.
Interventions
- DEVICE Reveal® DX or Reveal® XT Insertable Cardiac Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2010-08 |
| Est. Completion | 2011-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01168427
The ClinicalTrials.gov registry entry for NCT01168427 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Cardiac Rhythm and Heart Failure, which has 115 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Reveal® DX or Reveal® XT Insertable Cardiac Monitor is the first listed.
NCT01168427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01168427 about?
NCT01168427 is a clinical study titled "Reveal In-Office Implants". The purpose of this study is to gather evidence about the safety and feasibility of performing the implant procedure for the Reveal Insertable Cardiac Monitor (ICM) in an office or clinic setting rather than the traditional hospital operating room, cardiac catheterization or electrophysiology (EP) l...
What is the current status of trial NCT01168427?
This trial is currently completed. The enrollment target is 66 participants. The study started on 2010-08. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01168427?
The interventions under investigation include: Reveal® DX or Reveal® XT Insertable Cardiac Monitor (DEVICE).
Who is sponsoring clinical trial NCT01168427?
This trial is sponsored by Medtronic Cardiac Rhythm and Heart Failure, which has 115 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.